• 2025
  Alvarez J, Boklund A, Dippel S, Dórea F, Figuerola J, Herskin MS, Michel V, Miranda Chueca MÁ, Nannoni E, Nielsen SS, Nonno R, Riber AB, Stegeman JA, Ståhl K, Thulke HH, Tuyttens F, Winckler C, Brugerolles C, Wolff T, Parys A, Lindh E, Latorre-Margalef N, Rameix Welti MA, Dürrwald R, Trebbien R, Van der Werf S, Gisslén M, Monne I, Fusaro A, Guinat C, Bortolami A, Alexakis L, Enkirch T, Svartstrom O, Willgert K, Baldinelli F, Preite L, Grant M, Broglia A, Melidou A, Preparedness, prevention and control related to zoonotic avian influenza., EFSA J 2025 Jan; 23(1): e9191.
• 2024
  Dugied G, Douche T, Dos Santos M, Giai Gianetto Q Q, Cassonnet C, Vuillier F, Cassonnet P, Jacob Y, van der Werf S, Komarova A, Matondo M, Karim M, Demeret C, Profiling Cullin4-E3 ligases interactomes and their rewiring in influenza A virus infection., Mol Cell Proteomics 2024 Oct; (): 100856.
• 2024
  Inizan C, Courtot A, Sturmach C, Griffon AF, Biron A, Bruel T, Enouf V, Demaneuf T, Munier S, Schwartz O, Gourinat AC, Médevielle G, Jouan M, van der Werf S, Madec Y, Albert-Dunais V, Dupont-Rouzeyrol M, Levels and functionality of Pacific Islanders’ hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia., PLoS Med 2024 Sep; 21(9): e1004397.
• 2024
  Planchais C, Fernández I, Chalopin B, Bruel T, Rosenbaum P, Beretta M, Dimitrov JD, Conquet L, Donati F, Prot M, Porrot F, Planas D, Staropoli I, Guivel-Benhassine F, Baquero E, van der Werf S, Haouz A, Simon-Lorière E, Montagutelli X, Maillère B, Rey FA, Guardado-Calvo P, Nozach H, Schwartz O, Mouquet H, Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2., iScience 2024 Jul; 27(7): 110354.
• 2023
  Temmam S, Tu TC, Regnault B, Bonomi M, Chrétien D, Vendramini L, Duong TN, Phong TV, Yen NT, Anh HN, Son TH, Anh PT, Amara F, Bigot T, Munier S, Thong VD, van der Werf S, Nam VS, Eloit M, Genotype and Phenotype Characterization of Rhinolophus sp. Sarbecoviruses from Vietnam: Implications for Coronavirus Emergence., Viruses 2023 Sep; 15(9): .
• 2023
  Touret F, Giraud E, Bourret J, Donati F, Tran-Rajau J, Chiaravalli J, Lemoine F, Agou F, Simon-Lorière E, van der Werf S, de Lamballerie X, Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages., iScience 2023 Apr; 26(4): 106413.
• 2023
  Sarah Temmam, Xavier Montagutelli, Cécile Herate, Flora Donati, Béatrice Regnault, Mikael Attia, Eduard Baquero Salazar, Delphine Chretien, Laurine Conquet, Grégory Jouvion, Juliana Pipoli da Fonseca, Thomas Cokelaer, Faustine Amara, Francis Relouzat, Thibaut Naninck, Julien Lemaitre, Nathalie Derreudre-Bosquet, Quentin Pascal, Massimiliano Bonomi, Thomas Bigot, Sandie Munier, Felix Rey, Roger Le Grand, Sylvie van der Werf, Marc Eloit, SARS‐CoV‐2‐related bat virus behavior in human‐relevant models sheds light on the origin of COVID‐19, EMBO Reports, 2023, 24 (4), pp.e56055. ⟨10.15252/embr.202256055⟩.
• 2023
  Chen KY, Karuppusamy J, O'Neill MB, Opuu V, Bahin M, Foulon S, Ibanez P, Quintana-Murci L, Ozawa T, van der Werf S, Nghe P, Naffakh N, Griffiths A, Isel C , High-throughput droplet-based analysis of influenza A virus genetic reassortment by single-virus RNA sequencing., Proc Natl Acad Sci U S A 2023 Feb; 120(6): e2211098120.
• 2022
  Bruel T, Pinaud L, Tondeur L, Planas D, Staropoli I, Porrot F, Guivel-Benhassine F, Attia M, Pelleau S, Woudenberg T, Duru C, Koffi AD, Castelain S, Fernandes-Pellerin S, Jolly N, De Facci LP, Roux E, Ungeheuer MN, Van Der Werf S, White M, Schwartz O, Fontanet A, Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study., EClinicalMedicine 2022 Sep; 51(): 101576.
• 2022
  Vabret N, Najburg V, Solovyov A, Gopal R, McClain C, Šulc P, Balan S, Rahou Y, Beauclair G, Chazal M, Varet H, Legendre R, Sismeiro O, Sanchez David RY, Chauveau L, Jouvenet N, Markowitz M, van der Werf S, Schwartz O, Tangy F, Bhardwaj N, Greenbaum BD, Komarova AV, Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1., iScience 2022 Jul; 25(7): 104599.
• 2022
  Wu Y, Mahtal N, Paillares E, Swistak L, Sagadiev S, Acharya M, Demeret C, Werf SV, Guivel-Benhassine F, Schwartz O, Petracchini S, Mettouchi A, Caramelle L, Couvineau P, Thai R, Barbe P, Keck M, Brodin P, Machelart A, Sencio V, Trottein F, Sachse M, Chicanne G, Payrastre B, Ville F, Kreis V, Popoff MR, Johannes L, Cintrat JC, Barbier J, Gillet D, Lemichez E, , C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virus., iScience 2022 Jul; 25(7): 104537.
• 2022
  Planchais C, Fernández I, Bruel T, de Melo GD, Prot M, Beretta M, Guardado-Calvo P, Dufloo J, Molinos-Albert LM, Backovic M, Chiaravalli J, Giraud E, Vesin B, Conquet L, Grzelak L, Planas D, Staropoli I, Guivel-Benhassine F, Hieu T, Boullé M, Cervantes-Gonzalez M, Ungeheuer MN, Charneau P, van der Werf S, Agou F, , , Dimitrov JD, Simon-Lorière E, Bourhy H, Montagutelli X, Rey FA, Schwartz O, Mouquet H, Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2., J Exp Med 2022 Jul; 219(7): .
• 2022
  Mac Kain A, Maarifi G, Aicher SM, Arhel N, Baidaliuk A, Munier S, Donati F, Vallet T, Tran QD, Hardy A, Chazal M, Porrot F, OhAinle M, Carlson-Stevermer J, Oki J, Holden K, Zimmer G, Simon-Lorière E, Bruel T, Schwartz O, van der Werf S, Jouvenet N, Nisole S, Vignuzzi M, Roesch F, Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen., Nat Commun 2022 May; 13(1): 2442.
• 2022
  Molino D, Durier C, Radenne A, Desaint C, Ropers J, Courcier S, Vieillard LV, Rekacewicz C, Parfait B, Appay V, Batteux F, Barillot E, Cogné M, Combadière B, Eberhardt CS, Gorochov G, Hupé P, Ninove L, Paul S, Pellegrin I, van der Werf S, Lefebvre M, Botelho-Nevers E, Ortega-Perez I, Jaspard M, Sow S, Lelièvre JD, de Lamballerie X, Kieny MP, Tartour E, Launay O, A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project., Nat Med 2022 May; 28(5): 882-884.
• 2022
  Sarah Temmam, Khamsing Vongphayloth, Eduard Baquero, Sandie Munier, Massimiliano Bonomi, Béatrice Regnault, Bounsavane Douangboubpha, Yasaman Karami, Delphine Chrétien, Daosavanh Sanamxay, Vilakhan Xayaphet, Phetphoumin Paphaphanh, Vincent Lacoste, Somphavanh Somlor, Khaithong Lakeomany, Nothasin Phommavanh, Philippe Pérot, Océane Dehan, Faustine Amara, Flora Donati, Thomas Bigot, Michael Nilges, Félix Rey, Sylvie van Der Werf, Paul Brey, Marc Eloit, Bat coronaviruses related to SARS-CoV-2 and infectious for human cells, Nature, 2022, 604 (7905), pp.330-336. ⟨10.1038/s41586-022-04532-4⟩.
• 2022
  Montagutelli X, van der Werf S, Rey FA, Simon-Loriere E, SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillance., EMBO Mol Med 2022 Mar; 14(3): e15558.
• 2022
  Di Gioacchino A, Legendre R, Rahou Y, Najburg V, Charneau P, Greenbaum BD, Tangy F, van der Werf S, Cocco S, Komarova AV, sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs., RNA 2022 Mar; 28(3): 277-289.
• 2022
  Bastard J, Taisne B, Figoni J, Mailles A, Durand J, Fayad M, Josset L, Maisa A, van der Werf S, Parent du Châtelet I, Bernard-Stoecklin S, Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022., Euro Surveill 2022 Mar; 27(13): .
• 2022
  Sulbaran G, Maisonnasse P, Amen A, Effantin G, Guilligay D, Dereuddre-Bosquet N, Burger JA, Poniman M, Grobben M, Buisson M, Dergan Dylon S, Naninck T, Lemaître J, Gros W, Gallouët AS, Marlin R, Bouillier C, Contreras V, Relouzat F, Fenel D, Thepaut M, Bally I, Thielens N, Fieschi F, Schoehn G, van der Werf S, van Gils MJ, Sanders RW, Poignard P, Le Grand R, Weissenhorn W, Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection., Cell Rep Med 2022 Feb; 3(2): 100528.
• 2022
  Singh M, Chazal M, Quarato P, Bourdon L, Malabat C, Vallet T, Vignuzzi M, van der Werf S, Behillil S, Donati F, Sauvonnet N, Nigro G, Bourgine M, Jouvenet N, Cecere G, A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection., EMBO Rep 2022 Feb; 23(2): e54341.
• 2022
  Fillâtre P, Dufour MJ, Behillil S, Vatan R, Reusse P, Gabellec A, Velmans N, Montagne C, Geffroy Du Coudret S, Droumaguet E, Merour V, Enouf V, Buzelé R, Valence M, Guillotel E, Gagnière B, Baidaliuk A, Zhukova A, Tourdjman M, Thibault V, Grolhier C, Pronier C, Lescure FX, Simon-Loriere E, Costagliola D, Van Der Werf S, Tattevin P, Massart N, A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study., Clin Microbiol Infect 2022 Feb; 28(2): 298.e9-298.e15.
• 2022
  Bonnet C, Masse S, Benamar H, Vilcu AM, Swital M, Hanslik T, van der Werf S, Duval X, Carrat F, Falchi A, Blanchon T, Is the Alpha Variant of SARS-CoV-2 Associated with a Higher Viral Load than the Historical Strain in Saliva Samples in Patients with Mild to Moderate Symptoms?, Life (Basel) 2022 Jan; 12(2): .
• 2022
  Bratuleanu BE, Temmam S, Munier S, Chrétien D, Bigot T, van der Werf S, Savuta G, Eloit M, Detection of Phenuiviridae, Chuviridae Members, and a Novel Quaranjavirus in Hard Ticks From Danube Delta., Front Vet Sci 2022 ; 9(): 863814.
• 2022
  Maisonnasse P, Poynard T, Sakka M, Akhavan S, Marlin R, Peta V, Deckmyn O, Ghedira NB, Ngo Y, Rudler M, van der Werf S, Marot S, Thabut D, Sokol H, Housset C, Combes A, Le Grand R, Cacoub P, Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection., Gastro Hep Adv 2022 ; 1(3): 393-402.
• 2021
  Charmet T, Schaeffer L, Grant R, Galmiche S, Chény O, Von Platen C, Maurizot A, Rogoff A, Omar F, David C, Septfons A, Cauchemez S, Gaymard A, Lina B, Lefrancois LH, Enouf V, van der Werf S, Mailles A, Levy-Bruhl D, Carrat F, Fontanet A, , Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France., Lancet Reg Health Eur 2021 Sep; 8(): 100171.
• 2021
  Woudenberg T, Pelleau S, Anna F, Attia M, Donnadieu F, Gravet A, Lohmann C, Seraphin H, Guiheneuf R, Delamare C, Stefic K, Marlet J, Brochot E, Castelain S, Augereau O, Sibilia J, Dubos F, Meddour D, Guen CG, Coste-Burel M, Imbert-Marcille BM, Chauvire-Drouard A, Schweitzer C, Gatin A, Lomazzi S, Joulié A, Haas H, Cantais A, Bertholon F, Chinazzo-Vigouroux MF, Abdallah MS, Arowas L, Charneau P, Hoen B, Demeret C, Werf SV, Fontanet A, White M, , Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France., EBioMedicine 2021 Aug; 70(): 103495.
• 2021
  Le Vu S, Jones G, Anna F, Rose T, Richard JB, Bernard-Stoecklin S, Goyard S, Demeret C, Helynck O, Escriou N, Gransagne M, Petres S, Robin C, Monnet V, Perrin de Facci L, Ungeheuer MN, Léon L, Guillois Y, Filleul L, Charneau P, Lévy-Bruhl D, van der Werf S, Noel H, , Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance., Nat Commun 2021 05; 12(1): 3025.
• 2021
  Planas D, Bruel T, Grzelak L, Guivel-Benhassine F, Staropoli I, Porrot F, Planchais C, Buchrieser J, Rajah MM, Bishop E, Albert M, Donati F, Prot M, Behillil S, Enouf V, Maquart M, Smati-Lafarge M, Varon E, Schortgen F, Yahyaoui L, Gonzalez M, De Sèze J, Péré H, Veyer D, Sève A, Simon-Lorière E, Fafi-Kremer S, Stefic K, Mouquet H, Hocqueloux L, van der Werf S, Prazuck T, Schwartz O, Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies., Nat Med 2021 May; 27(5): 917-924.
• 2021
  Pierre Garneret,Etienne Coz, Elian Martin, Jean-Claude Manuguerra, Elodie Brient-Litzler, Vincent Enouf, Daniel Felipe González Obando, Jean-Christophe Olivo-Marin, Fabrice Monti, Sylvie van der Werf, Jessica Vanhomwegen, Patrick Tabeling, Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification, PLOS ONE, 16(1), e0243712 - January 2021.
• 2020
  Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Rajah MM, Planchais C, Porrot F, Guivel-Benhassine F, Van der Werf S, Casartelli N, Mouquet H, Bruel T, Schwartz O, , Syncytia formation by SARS-CoV-2-infected cells., EMBO J 2020 12; 39(23): e106267.
• 2020
  Declercq M, Biquand E, Karim M, Pietrosemoli N, Jacob Y, Demeret C, Barbezange C, van der Werf S, , Influenza A virus co-opts ERI1 exonuclease bound to histone mRNA to promote viral transcription., Nucleic Acids Res. 2020 Sep; (): .
• 2020
  Ludivine Grzelak, Sarah Temmam, Cyril Planchais, Caroline Demeret, Laura Tondeur, Christèle Huon, Florence Guivel-Benhassine, Isabelle Staropoli, Maxime Chazal, Jeremy Dufloo, Delphine Planas, Julian Buchrieser, Maaran Michael Rajah, Remy Robinot, Françoise Porrot, Mélanie Albert, Kuang-Yu Chen, Bernadette Crescenzo-Chaigne, Flora Donati, François Anna, Philippe Souque, Marion Gransagne, Jacques Bellalou, Mireille Nowakowski, Marija Backovic, Lila Bouadma, Lucie Le Fevre, Quentin Le Hingrat, Diane Descamps, Annabelle Pourbaix, Cédric Laouénan, Jade Ghosn, Yazdan Yazdanpanah, Camille Besombes, Nathalie Jolly, Sandrine Pellerin-Fernandes, Olivia Cheny, Marie-Noëlle Ungeheuer, Guillaume Mellon, Pascal Morel, Simon Rolland, Felix Rey, Sylvie Behillil, Vincent Enouf, Audrey Lemaitre, Marie-Aude Créach, Stéphane Pêtres, Nicolas Escriou, Pierre Charneau, Arnaud Fontanet, Bruno Hoen, Timothée Bruel, Marc Eloit, Hugo Mouquet, Olivier Schwartz, Sylvie van Der Werf, A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations, Science Translational Medicine, 2020, 12 (559), pp.eabc3103. ⟨10.1126/scitranslmed.abc3103⟩.
• 2020
  Pierre Garneret, Etienne Coz, Elian Martin, Jean-Claude Manuguerra, Elodie Brient-Litzler, Vincent Enouf, Daniel Felipe Gonzalez Obando, Jean-Christophe Olivo-Marin, Fabrice Monti, Sylvie Van der Werf, Jessica Vanhomwegen, Patrick Jean Tabeling, Highly performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification., medRxiv 2020.08.01.20166538.
• 2020
  Gámbaro F, Behillil S, Baidaliuk A, Donati F, Albert M, Alexandru A, Vanpeene M, Bizard M, Brisebarre A, Barbet M, Derrar F, van der Werf S, Enouf V, Simon-Loriere E, , Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020., Euro Surveill. 2020 07; 25(26): .
• 2020
  Sylvie van Der Werf, Cécile Peltekian, Émergence du coronavirus SARS-CoV-2 : faire face à l’épidémie de COVID-19 Facing challenges with the novel coronavirus SARS-CoV-2 outbreak, Virologie, 2020, 24 (S1), pp.S3-S6. ⟨10.1684/vir.2020.0825⟩.
• 2017
  Domenech de Cellès M, Arduin H, Varon E, Souty C, Boëlle PY, Lévy-Bruhl D, van der Werf S, Soulary JC, Guillemot D, Watier L, Opatowski L, Characterizing and Comparing the Seasonality of Influenza-Like Illnesses and Invasive Pneumococcal Diseases Using Seasonal Waveforms, Am. J. Epidemiol. 2018 05;187(5):1029-1039.
• 2014
  Crescenzo-Chaigne B, Barbezange C, Frigard V, Poulain D, van der Werf S, Chimeric NP non coding regions between type A and C influenza viruses reveal their role in translation regulation, PLoS ONE 2014;9(9):e109046.
• 2013
  Crescenzo-Chaigne B, Barbezange C, van der Werf S, The Panhandle formed by influenza A and C virus NS non-coding regions determines NS segment expression, PLoS ONE 2013;8(11):e81550.
• 2013
  Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, Enouf V, van der Werf S, Ferguson NM, Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility, Lancet Infect Dis 2014 Jan;14(1):50-56.
• 2013
  Desdouits M, Munier S, Prevost MC, Jeannin P, Butler-Browne G, Ozden S, Gessain A, Van Der Werf S, Naffakh N, Ceccaldi PE, Productive infection of human skeletal muscle cells by pandemic and seasonal influenza A(H1N1) viruses, PLoS ONE 2013;8(11):e79628.
• 2013
  Opatowski L, Varon E, Dupont C, Temime L, van der Werf S, Gutmann L, Boëlle PY, Watier L, Guillemot D, Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models, Proc. Biol. Sci. 2013 Aug;280(1764):20130519.
• 2009
  Naffakh N, van der Werf S, April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission, Microbes Infect. 2009 Jul-Aug;11(8-9):725-8.
• 2008
  Crescenzo-Chaigne B, Barbezange C, van der Werf S, Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes, Virol. J. 2008;5:132.
• 2007
  Crescenzo-Chaigne B, van der Werf S, Rescue of influenza C virus from recombinant DNA, J. Virol. 2007 Oct;81(20):11282-9.
• 2007
  Buchy P, Mardy S, Vong S, Toyoda T, Aubin JT, Miller M, Touch S, Sovann L, Dufourcq JB, Richner B, Tu PV, Tien NT, Lim W, Peiris JS, Van der Werf S, Influenza A/H5N1 virus infection in humans in Cambodia, J. Clin. Virol. 2007 Jul;39(3):164-8.
• 2007
  Medeiros R, Rameix-Welti MA, Lorin V, Ribaud P, Manuguerra JC, Socie G, Scieux C, Naffakh N, van der Werf S, , Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus., Antivir Ther 2007 ; 12(4): 571-6.
• 2005
  Vieira Machado A, Naffakh N, Gerbaud S, van der Werf S, Escriou N, Recombinant influenza A viruses harboring optimized dicistronic NA segment with an extended native 5′ terminal sequence: induction of heterospecific B and T cell responses in mice, Virology 2006 Feb;345(1):73-87.
• 2005
  Massin P, Rodrigues P, Marasescu M, van der Werf S, Naffakh N, Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells, J. Virol. 2005 Nov;79(21):13811-6.
• 2005
  Dos Santos Afonso E, Escriou N, Leclercq I, van der Werf S, Naffakh N, The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5′ end of the PB2 segment, Virology 2005 Oct;341(1):34-46.
• 2003
  Machado AV, Naffakh N, van der Werf S, Escriou N, Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter, Virology 2003 Aug;313(1):235-49.
• 2003
  Alonso JM, Guiyoule A, Zarantonelli ML, Ramisse F, Pires R, Antignac A, Deghmane AE, Huerre M, van der Werf S, Taha MK, , A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice., FEMS Microbiol Lett 2003 May; 222(1): 99-106.
• 2002
  Crescenzo-Chaigne B, van der Werf S, Naffakh N, Differential effect of nucleotide substitutions in the 3′ arm of the influenza A virus vRNA promoter on transcription/replication by avian and human polymerase complexes is related to the nature of PB2 amino acid 627, Virology 2002 Nov;303(2):240-52.
• 2002
  Vignuzzi M, Gerbaud S, van der Werf S, Escriou N, Expression of a membrane-anchored glycoprotein, the influenza virus hemagglutinin, by dicistronic replicons derived from the poliovirus genome, J. Virol. 2002 May;76(10):5285-90.